查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930081

全球生物資訊市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034）

Bioinformatics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 請詢問到貨日

價格

生物資訊市場的成長驅動因素

全球生物資訊市場已成為現代生命科學的關鍵支柱，其成長動力源於對海量生物數據進行管理、分析和解讀的日益增長的需求。根據 Fortune Business Insights 預測，生物資訊市場規模預計在 2025 年達到 317.4 億美元，並在 2026 年顯著增長至 384.5 億美元。在基因組學、藥物研發和個人化醫療等領域的日益普及推動下，該市場預計到 2034 年將達到 1,182.5 億美元，2026 年至 2034 年的複合年增長率 (CAGR) 為 15.08%。 生物資訊學將計算工具與生物科學結合，用於分析基因組學、蛋白質組學和代謝組學數據。這些能力對於理解疾病機制、發現新的藥物標靶和改善臨床療效至關重要。全球慢性病發病率的上升以及臨床和基因組學研究的快速發展是推動市場擴張的關鍵因素。

市場驅動因素與成長因素

生物資訊市場的主要成長驅動因素之一是政府和私人機構對基因組研究投入的不斷增加。大規模基因組定序計畫會產生大量資料集，而這些資料集的分析和解讀需要先進的生物資訊平台。例如，對全基因組定序計畫和罕見疾病研究的投資正在加速對生物資訊軟體和服務的需求。

此外，生物資訊學在整個藥物研發生命週期中發揮關鍵作用，包括標靶識別、分子建模、毒性預測和生物標記發現。這使得製藥和生技公司能夠縮短研發週期並降低研發成本，從而進一步加速其應用。

新冠疫情也對市場產生了正面影響。生物資訊工具被廣泛用於分析病毒基因組序列、闡明突變模式以及支持疫苗研發。自 2021 年以來，這些解決方案在傳染病研究和臨床試驗中的應用不斷擴展，持續支撐著市場的穩定成長。

市場趨勢：人工智慧與機器學習的融合

人工智慧 (AI) 和機器學習 (ML) 的融合是塑造全球生物資訊市場的關鍵趨勢。這些技術有助於從複雜且非結構化的生物數據集中提取有意義的信息，改進預測模型，並實現個人化醫療。人工智慧驅動的生物資訊學平台正越來越多地應用於基因組學、表觀遺傳學和腫瘤學研究，從而提高數據分析的準確性和可擴展性。

市場區隔分析

依產品/服務劃分

市場依產品/服務分為軟體及服務兩大類。

軟體領域佔市場主導地位，預計到 2026 年將佔 79.67% 的市場佔有率，這主要得益於定序、數據分析和視覺化平台在研究和藥物發現領域的廣泛應用。服務領域也保持穩定成長，這得益於臨床研究和學術機構需求的不斷增長。

依應用領域劃分

應用領域包括基因體學、藥理學、代謝組學、轉錄組學等。

基因組學領域佔了最大的市場佔有率，預計到2026年將達到35.29%，這主要得益於測序技術的持續進步以及公共和私人對基因組學研究投資的不斷增加。藥理學和代謝組學也是關鍵領域，因為它們在藥物代謝和治療開發中發揮重要作用。

依最終使用者劃分

以最終用戶劃分，製藥和生技公司將主導市場，預計到2026年將佔45.13%的市場佔有率。這一主導地位歸功於策略聯盟、研發支出的成長以及生物資訊學在精準醫療和腫瘤學計畫中的整合。

區域考量

北美將在2025年以46.23%的市場佔有率引領全球生物資訊市場，這得益於主要解決方案提供商的強大實力、完善的研究基礎設施以及政府支持的基因組學計劃。

歐洲將緊隨其後，由於對個人化醫療和下一代定序的投資，將呈現顯著成長。

亞太地區預計將在預測期內實現最高的複合年增長率，這主要得益於中國、日本和印度等國家臨床試驗的增加以及基因組學研究的拓展。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 關鍵產業趨勢：併購、業務合作
  • 生物資訊科技進步
  • 新冠疫情對市場的影響

第五章 全球生物資訊市場分析：洞察與預測 （2021-2034）

  • 市場分析、洞察與預測：依產品類型劃分
    • 軟體
    • 服務
  • 市場分析、洞察與預測：依應用領域劃分
    • 代謝組學
    • 藥理學
    • 基因體學
    • 轉錄組學
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 製藥和生技公司
    • 合約研究組織 (CRO)、研究機構
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

章節第六章 北美生物資訊市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲生物資訊市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家

第八章 亞太生物資訊市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 亞太其他地區

第九章：拉丁美洲生物資訊市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲生物資訊市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會（GCC）成員國
    • 南非
    • 中東和非洲其他地區

第十一章 競爭格局分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • DNAnexus, Inc.
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • IBM Corporation
    • Labvantage-Biomax GmbH
    • Genebio
    • Compugen Ltd.
    • Eurofins Scientific
    • QIAGEN
Product Code: FBI109493

Growth Factors of bioinformatics Market

The global bioinformatics market has emerged as a critical pillar of modern life sciences, driven by the growing need to manage, analyze, and interpret vast volumes of biological data. According to Fortune Business Insights, the bioinformatics market size was valued at USD 31.74 billion in 2025 and is projected to expand significantly to USD 38.45 billion in 2026. With increasing adoption across genomics, drug discovery, and personalized medicine, the market is forecasted to reach USD 118.25 billion by 2034, registering a strong CAGR of 15.08% during 2026-2034.

Bioinformatics integrates computational tools with biological sciences to analyze genomic, proteomic, and metabolomic data. These capabilities are increasingly vital for understanding disease mechanisms, discovering novel drug targets, and improving clinical outcomes. The rising global burden of chronic diseases and the rapid growth in clinical and genomic research are key contributors to market expansion.

Market Drivers and Growth Factors

One of the primary growth drivers of the bioinformatics market is the increased funding for genomics research by governments and private organizations. Large-scale genome sequencing initiatives generate enormous datasets that require advanced bioinformatics platforms for analysis and interpretation. For instance, investments in whole-genome sequencing programs and rare disease research are accelerating demand for bioinformatics software and services.

Additionally, bioinformatics plays a crucial role across the entire drug discovery lifecycle, including target identification, molecular modeling, toxicity prediction, and biomarker discovery. This has enabled pharmaceutical and biotechnology companies to shorten development timelines and reduce R&D costs, further driving adoption.

The COVID-19 pandemic also had a positive impact on the market. Bioinformatics tools were extensively used to analyze viral genome sequences, understand mutation patterns, and support vaccine development. Since 2021, the expanded application of these solutions in infectious disease research and clinical trials has continued to support steady market growth.

Market Trends: AI and Machine Learning Integration

A major trend shaping the global bioinformatics market is the integration of artificial intelligence (AI) and machine learning (ML). These technologies help extract meaningful insights from complex and unstructured biological datasets, improve predictive modeling, and enable personalized medicine. AI-driven bioinformatics platforms are increasingly used in genomics, epigenetics, and oncology research, enhancing accuracy and scalability in data analysis.

Market Segmentation Analysis

By Offering

Based on offerings, the market is segmented into software and services.

The software segment dominated the market, accounting for 79.67% share in 2026, due to high adoption of sequencing, data analysis, and visualization platforms in research and drug discovery. The services segment is also growing steadily, supported by rising demand from clinical research organizations and academic institutes.

By Application

By application, the market includes genomics, pharmacology, metabolomics, transcriptomics, and others.

The genomics segment held the largest share at 35.29% in 2026, driven by continuous advancements in sequencing technologies and increasing public and private investment in genomic research. Pharmacology and metabolomics also represent significant segments due to their importance in drug metabolism and therapeutic development.

By End User

In terms of end users, pharmaceutical and biotechnology companies dominated the market with a 45.13% share in 2026. This dominance is attributed to strategic collaborations, increased R&D spending, and the integration of bioinformatics into precision medicine and oncology programs.

Regional Insights

North America dominated the global bioinformatics market with a 46.23% share in 2025, supported by strong presence of leading solution providers, robust research infrastructure, and government-backed genomics initiatives.

Europe followed with notable growth due to investments in personalized medicine and next-generation sequencing.

The Asia Pacific region is expected to record the highest CAGR during the forecast period, fueled by rising clinical trials and expanding genomics research in countries such as China, Japan, and India.

Competitive Landscape

The bioinformatics market is moderately consolidated, with key players such as Illumina, QIAGEN, Thermo Fisher Scientific, Agilent Technologies, IBM Corporation, and Eurofins Scientific holding significant market positions. These companies focus on strategic partnerships, cloud-based platforms, and AI-enabled solutions to strengthen their global footprint.

Conclusion

In conclusion, the global bioinformatics market, valued at USD 31.74 billion in 2025, is set for robust expansion, reaching USD 118.25 billion by 2034. Strong investment in genomics research, technological advancements, and growing adoption in drug discovery and personalized medicine will continue to drive market growth during the forecast period.

Segmentation By Offering

  • Software
  • Services

By Application

  • Metabolomics
  • Pharmacology
  • Genomics
  • Transcriptomics
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • CROs & Research Institutes
  • Others

By Region

  • North America (By Offering, Application, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Offering, Application, End-User, and Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Offering, Application, End-User, and Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Offering, Application, End-User, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Application, End-User, and Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.2. Technological Advancement in Bioinformatics
  • 4.3. Impact of COVID-19 on the Market

5. Global Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offerings
    • 5.1.1. Software
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Metabolomics
    • 5.2.2. Pharmacology
    • 5.2.3. Genomics
    • 5.2.4. Transcriptomics
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Pharmaceutical & Biotechnological Companies
    • 5.3.2. CROs & Research Institutes
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offerings
    • 6.1.1. Software
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Metabolomics
    • 6.2.2. Pharmacology
    • 6.2.3. Genomics
    • 6.2.4. Transcriptomics
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Pharmaceutical & Biotechnological Companies
    • 6.3.2. CROs & Research Institutes
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offerings
    • 7.1.1. Software
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Metabolomics
    • 7.2.2. Pharmacology
    • 7.2.3. Genomics
    • 7.2.4. Transcriptomics
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Pharmaceutical & Biotechnological Companies
    • 7.3.2. CROs & Research Institutes
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Rest of Europe

8. Asia Pacific Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offerings
    • 8.1.1. Software
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Metabolomics
    • 8.2.2. Pharmacology
    • 8.2.3. Genomics
    • 8.2.4. Transcriptomics
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Pharmaceutical & Biotechnological Companies
    • 8.3.2. CROs & Research Institutes
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Rest of Asia Pacific

9. Latin America Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offerings
    • 9.1.1. Software
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Metabolomics
    • 9.2.2. Pharmacology
    • 9.2.3. Genomics
    • 9.2.4. Transcriptomics
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Pharmaceutical & Biotechnological Companies
    • 9.3.2. CROs & Research Institutes
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Bioinformatics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offerings
    • 10.1.1. Software
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Metabolomics
    • 10.2.2. Pharmacology
    • 10.2.3. Genomics
    • 10.2.4. Transcriptomics
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Pharmaceutical & Biotechnological Companies
    • 10.3.2. CROs & Research Institutes
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. DNAnexus, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Illumina, Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Agilent Technologies, Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Thermo Fisher Scientific Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. IBM Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Labvantage - Biomax GmbH
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Genebio
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Compugen Ltd.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Eurofins Scientific
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. QIAGEN
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 2: Global Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 4: Global Bioinformatics Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 6: North America Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 8: North America Bioinformatics Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 10: Europe Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Europe Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 12: Europe Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 14: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 16: Asia Pacific Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 18: Latin America Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Latin America Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 20: Latin America Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, by Offerings, 2021-2034
  • Table 22: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 24: Middle East & Africa Bioinformatics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Bioinformatics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Bioinformatics Market Value Share (%), by Offerings, 2025 & 2034
  • Figure 3: Global Bioinformatics Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Bioinformatics Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Bioinformatics Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
  • Figure 7: North America Bioinformatics Market Value Share (%), by Offerings, 2025
  • Figure 8: North America Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Bioinformatics Market Value Share (%), by Application, 2025
  • Figure 10: North America Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Bioinformatics Market Value Share (%), by End User, 2025
  • Figure 12: North America Bioinformatics Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Bioinformatics Market Value Share (%), By Country, 2025
  • Figure 14: Europe Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
  • Figure 15: Europe Bioinformatics Market Value Share (%), by Offerings, 2025
  • Figure 16: Europe Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Bioinformatics Market Value Share (%), by Application, 2025
  • Figure 18: Europe Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Bioinformatics Market Value Share (%), by End User, 2025
  • Figure 20: Europe Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
  • Figure 23: Asia Pacific Bioinformatics Market Value Share (%), by Offerings, 2025
  • Figure 24: Asia Pacific Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Bioinformatics Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Bioinformatics Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
  • Figure 31: Latin America Bioinformatics Market Value Share (%), by Offerings, 2025
  • Figure 32: Latin America Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Bioinformatics Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Bioinformatics Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Bioinformatics Market Value (USD billion), by Offerings, 2025 & 2034
  • Figure 39: Middle East & Africa Bioinformatics Market Value Share (%), by Offerings, 2025
  • Figure 40: Middle East & Africa Bioinformatics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Bioinformatics Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Bioinformatics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Bioinformatics Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Bioinformatics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Bioinformatics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Bioinformatics Market Share (%), By Company, 2025